KRSNAA DIAGNOSTICS LTD.

NSE : KRSNAABSE : 543328ISIN CODE : INE08LI01020Industry : Hospital & Healthcare ServicesHouse : Private
BSE584.55-8.25 (-1.39 %)
PREV CLOSE ( ) 592.80
OPEN PRICE ( ) 589.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 6679
TODAY'S LOW / HIGH ( )582.25 594.90
52 WK LOW / HIGH ( )448.7 788.6
NSE583.55-8.05 (-1.36 %)
PREV CLOSE( ) 591.60
OPEN PRICE ( ) 592.80
BID PRICE (QTY) 583.55 (207)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 82816
TODAY'S LOW / HIGH( ) 581.75 595.70
52 WK LOW / HIGH ( )448.6 767.9
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 22-12 2010
Management Info
Rajendra Mutha - Chairman - Managing Director
Registered Office

Address S. No. 243, A- Hissa No. 6,Cts No. 4519, 4519/1, Near Chinchwad Station,Chinchwad, Taluka – Haveli,
Pune,
Maharashtra-411019

Phone 020-29780210 / 11 / 12

Email info@krsnadiagnostics.com

Website www.krsnaadiagnostics.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
02May Krsnaa Diagnostics inks pact with Gove
Krsnaa Diagnostics has signed the agreement on April 30, 2024, with the..
09Apr Krsnaa Diagnostics incorporates wholly
Krsnaa Diagnostics has incorporated wholly owned subsidiary namely ‘Krsn..
06Mar Krsnaa Diagnostics informs about newsp
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
05Mar Krsnaa Diagnostics informs about notic
With reference to letter no. KDL/SE/CI/02/2023-24 dated February 12, 202..
05Mar Krsnaa Diagnostics informs about analy
Krsnaa Diagnostics has informed that the officials of the Company will b..
Financials
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit135.85635.09
Gross Profit 168.67 821.91
Operating Profit 422.371436.56
Net Sales 1515.524640.83
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
RainbowChildrenS Med (BSE)
 1461.55 (5.43%)
M.Cap (Rs. in Cr)14834.98
Apollo Hospital Ent. (BSE)
 6009.00 (0.89%)
M.Cap (Rs. in Cr)86400.20
Jupiter Life Line (BSE)
 1223.15 (1.41%)
M.Cap (Rs. in Cr)8019.71
HealthcareGlobal (BSE)
 369.50 (4.26%)
M.Cap (Rs. in Cr)5146.75
Fortis Healthcare (BSE)
 451.70 (2.52%)
M.Cap (Rs. in Cr)34101.46
Shareholding Pattern
NON-INSTITUTION 54.26%
PROMOTERS 27.03%
MUTUAL FUNDS/UTI 11.05%
FI/BANKS/INSURANCE 4.09%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.